Hi readers,
Last month, Rover Group, the world’s largest online pet care marketplace, announced it had acquired cat sitting platform Meowtel.
While the deal could be interpreted as simply an extension of Rover’s services, on closer inspection, the deal actually signals a structural shift and segmentation in the pet industry.
Read on to see how the deal is the latest indication that the feline space is increasingly a growth driver (and not just an extension of the dog economy).
On a different note, the Animal Health, Nutrition and Technology Innovation (AHNTI) conference is coming up on March 2-4 in London, with Feline Business Brief proud to be a media partner.
If you’re planning to join, AHNTI has kindly extended a 10% ticket discount to FBB readers (just click on the banner).
As always, if you’ll be there, we’d love to connect! Just reply to this email and let us know.
What we’re watching
While the industry watches dogs, strategic buyers are building the feline stack
At first glance, Rover’s acquisition of cat sitting platform Meowtel might seem like more business as usual. While mostly focused on dog services, Rover already offered cat sitting. Acquiring Meowtel could simply be interpreted as an expansion of an existing offering.
But when put into context with other recent industry moves, the Rover-Meowtel deal actually signals a structural shift within the pet space.
Increasingly, large pet industry players are buying feline assets strategically and assembling feline ‘stacks’; that is, an ecosystem of services, therapeutics, nutrition and digital infrastructure built specifically around cats.
The shift indicates increasing recognition that the feline sector is becoming a growth driver in its own right. Cats are no longer being treated as a derivative of dog economics.
This means that Rover did not just acquire a cat-sitting marketplace, it is entering a space that is increasingly investable.
Feline-driven industry segmentation
Rover’s acquisition of Meowtel is the latest of several signals, across different verticals, of increasing segmentation within the pet industry:
In July 2025, The Nutriment Company acquired UK raw cat food brand Purrform. The Nutriment Company said it made the acquisition to strengthen its feline nutrition portfolio.
In December 2025, Virbac acquired feline hyperthyroidism treatments Felanorm and Thyronorm from Norbrook to expand its feline portfolio.
What’s noteworthy is that in each case, senior executives emphasised how the deal enabled them to acquire specialisation in the feline space.
Purrform, for example, had amassed a loyal customer base and expertise on raw, species-specific, and biologically appropriate feline diets.
Similarly, Virbac's acquisition “provides Virbac with a leading specialty product, in a growing segment, to improve the quality of life for senior cats,” the company said in a statement.
And Rover’s CEO, Brent Turner, highlighted this drive towards feline specialisation by acknowledging that Meowtel addressed cats’ unique care requirements, such as staying in their familiar environment and maintaining routines.
In addition, rather than becoming part of Rover’s brand, Meowtel will continue operating as a separate brand, under its own existing leadership team.
Private equity
Another interesting angle to the segmentation theme is the role of private equity behind these brands.
Private equity tends to prioritise scalable and repeatable revenue streams. Its growing presence across feline-focused businesses indicates that investors increasingly see the feline category as commercially attractive.
Rover was acquired by U.S. private equity firm Blackstone in February 2024, signalling institutional confidence in pet services platforms. In addition:
The Nutriment Company (which later acquired Purrform) is majority-owned by the Nordic private equity firm Axcel.
In June 2025, Partners Group acquired MPM Products for £400 million, targeting its strong position in the premium cat food market. MPM Products’ premium cat-focused brands include Applaws, Reveal, and Encore.
In January 2022, Worldwise, an A&M Capital portfolio company, acquired cat litter brand Kitty Sift.
Dogs have historically been more profitable because the services around them (e.g. grooming, daycare, training, walking) became organised and commercialised much earlier.
Cats, despite rising ownership, strong appeal for urban households, and deeply committed owners, have remained relatively overlooked.
This is definitely changing: When private equity begins consolidating a category, it usually reflects confidence in its ability to generate predictable, long-term returns. This is clearly a point that the feline sector has now reached.
What is the feline stack?
The ‘feline stack’ refers to a deliberately built ecosystem of products and services focused on cats, rather than models that are merely extensions of dog-focused models.
Services: Cat sitting, virtual care, insurance, and behaviour support are scaling as cat guardians seek models that respect cats’ preference for familiar environments and routines.
Nutrition: Premium, functional, and species-appropriate diets are gaining traction, reflecting growing awareness of cats’ unique metabolic and hydration needs.
Therapeutics: Investment is rising in areas such as feline chronic disease management, endocrinology, pain, and longevity. These segments have been historically underserved compared to canine medicine.
Consumables and enrichment: High-frequency categories including litter, supplements, smart feeders, and environmental enrichment are becoming innovation targets.
Digital infrastructure: Marketplaces, health platforms, and data-driven tools are beginning to bring these layers together.
When companies begin building integrated ecosystems rather than standalone offerings, it often signals a shift towards long-term strategic commitment.
This, in turn, indicates that the feline economy is entering a more structured phase of growth.
Feline Business Brief provides market intelligence on the global feline economy. We analyse early signals, emerging risks and structural shifts across feline nutrition, health, therapeutics, diagnostics, technology and retail.
